MIT Professor and 6 Alumni Elected to Top Medical Honor

The National Academy of Medicine welcomed seven MIT-connected researchers into its prestigious ranks this October, recognizing achievements that are transforming healthcare for millions.

Professor Michael Yaffe leads the group as MIT's David H. Koch Professor of Science and founding director of the MIT Center for Precision Cancer Medicine. His discovery of how proteins communicate during stress and cell division opened entirely new paths for understanding cancer at the molecular level.

Yaffe's work reads like detective science. He mapped how cells decide when to grow, repair themselves, or shut down after damage. These insights now guide researchers worldwide in developing smarter, more targeted cancer treatments that work with the body's natural systems instead of against them.

Beyond the lab, Yaffe served as a colonel in the U.S. Army Reserve Medical Corps, including deployment to Afghanistan. He balances his research with clinical work as a surgeon at Beth Israel Deaconess Medical Center, bringing bedside insights back to the bench.

Six MIT alumni join him in this honor: Steven Allen Abrams, Susan Ettner, Diane Medved Harper, Albert Icksang Ko, Jennifer Lewis, and Alexander Marson. Together, they span fields from economics of healthcare to infectious disease prevention.

The timing matters. As medicine grows increasingly complex, these researchers prove that fundamental science still drives real-world healing. Yaffe's phospho-binding domain discoveries might sound technical, but they helped birth systems biology, allowing scientists to predict how drugs will behave before they reach patients.

The Ripple Effect spreads far beyond individual labs. When researchers map the "Rosetta Stone" of cell signaling, as Yaffe's team has done, every cancer researcher gains a new tool. When health economists like Ettner analyze what treatments truly work, healthcare systems worldwide can allocate resources more wisely. When immunologists like Marson decode how our defenses recognize threats, vaccine development accelerates.

Election to the National Academy of Medicine represents more than personal achievement. Members advise policymakers, set research priorities, and mentor the next generation of medical innovators. NAM President Monica Bertagnolli emphasized their role in developing "evidence-based guidance and solutions for our country's greatest healthcare challenges."

The academy elected 100 new members total this year, drawing from medicine's brightest minds across specialties. The MIT contingent of seven reflects the institution's unique position bridging engineering, biology, chemistry, and clinical care.

These honors arrive as precision medicine moves from promise to practice, proving that yesterday's basic research becomes tomorrow's lifesaving treatment.